US Patent 9908895 Tricyclic fused thiophene derivatives as JAK inhibitors
Patent 9908895 was granted and assigned to Incyte on March, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+356 characters)
Article
Patent abstract
The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Joseph Glenn0
Song Mei0
Wenyu Zhu0
Yun-Long Li0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09908895 Tricyclic fused thiophene derivatives as JAK inhibitors US Patent 9908895 Tricyclic fused thiophene derivatives as JAK inhibitors
Infobox
Patent Number
099088950
Patent Number
99088950
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
099088950
Date of Patent
March 6, 2018
0Patent Application Number
148730780
Date Filed
October 1, 2015
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09908895 Tricyclic fused thiophene derivatives as JAK inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09908895
Date of patent
March 6, 2018
Patent application number
14873078
Date Filed
October 1, 2015
Patent primary examiner
Find more entities like US Patent 9908895 Tricyclic fused thiophene derivatives as JAK inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
